Mindfulness for Cognition in Early-stage Alzheimer's Disease
NCT06792877
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to learn if mindfulness meditation can improve outcomes in older adults with and without cognitive impairment. The main questions it aims to answer are: How does mindfulness impact thinking and memory? How does mindfulness influence brain function and structure? How does mindfulness affect daily function and quality of life? Researchers will compare all outcomes to one other groups.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Mild Cognitive Impairment (MCI)
- Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- TBI (Traumatic Brain Injury)
- Aging
- Healthy Elderly
- Alzheimer&Amp;Amp;#39;s Dementia (AD)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 50 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- VA Boston Healthcare System
- Last updated on ClinicalTrials.gov
- January 27, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 1
- VA Boston Healthcare System - Jamaica Plain Campus · Boston, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.